Program of cartoons made by the NFB of CanadaĪl Eugster (Alfred Eugster) (February 11, 1909–January 1, 1997) (animator, director) dies. doi: 10.1093/europace/eun250.Chronology of Animation 1997 Chronology of Animation 1997 Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial.
Gakkyu oh yamazaki watanabe trial#
Halimi F, Clémenty J, Attuel P, Dessenne X, Amara W OEDIPE trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A, Binet D, Daubert JC COMPAS Trial Investigators. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association. Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, Camm J. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Slotwiner D, Varma N, Akar JG, Annas G, Beardsall M, Fogel RI, Galizio NO, Glotzer TV, Leahy RA, Love CJ, et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Japan consensus insurance pacemaker stroke.ĭubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J, Piotrowicz R, Hayes DL, Kirchhof P, Breithardt G, et al. Registration: URL: Unique identifier: NCT01523704. Replacing periodic in-office follow-ups with remote follow-ups for 2 years in pacemaker patients committed to remote monitoring does not increase the occurrence of major cardiovascular events and reduces resource consumption. Only 1.4% of remote follow-ups triggered an unscheduled in-office follow-up, and only 1.5% of scheduled in-office follow-ups were considered actionable. Insurance claims for follow-ups and directly related diagnostic procedures were 18 800 Yen (16 500-20 700 Yen) in RFU and 21 400 Yen (16 700-25 900 Yen) in conventional follow-up ( P<0.001). The median (interquartile range) number of in-office follow-ups was 0.50 (0.50-0.63) in RFU and 2.01 (1.93-2.05) in conventional follow-up per patient-year ( P<0.001). The primary end point occurred in 10.9% and 11.8%, respectively ( P=0.0012 for noninferiority). Of 1274 randomized patients (50.4% female, age 77☑0 years), 558 (RFU) and 550 (Conventional follow-up) patients reached either the primary end point or 24 months follow-up. The primary end point was a composite of death, stroke, or cardiovascular events requiring surgery, and the primary hypothesis was noninferiority with 5% margin. RFU patients were only seen if indicated by remote monitoring. In Japan, consecutive pacemaker patients committed to remote monitoring were randomized to either RFU or conventional in-office follow-up (conventional follow-up) at twice yearly intervals. We studied safety and resource consumption of exclusive remote follow-up (RFU) in pacemaker patients for 2 years. 20 Department of Cardiology, Kokura Memorial Hospital, Fukuoka, Japan (K.A.).Ĭurrent expert consensus recommends remote monitoring for cardiac implantable electronic devices, with at least annual in-office follow-up.19 Cleveland Clinic, Heart & Vascular Institute, OH (N.V.).17 Department of Cardiology, Daido Hospital, Aichi, Japan (T.16 Department of Cardiology, Fukuyama Cardiovascular Hospital, Hiroshima, Japan (S.H.).15 Department of Cardiology, Kasukabe Chuo General Hospital, Saitama, Japan (K.T.).14 Department of Cardiology, Hiraka General Hospital, Akita, Japan (Y.S.).13 Department of Cardiology, JA Toride Medical Ctr, Ibaraki, Japan (T.T.).12 Department of Cardiology, Kochi Health Sciences Center, Japan (K.Y.).11 Department of Cardiology, Osaka Police Hospital, Japan (Y.U.).10 Department of Cardiology, Teikyo University Hospital (T.9 Department of Cardiology, Chiba University Hospital (M.U.), Tokyo, Japan.8 Department of Cardiology, Japanese Red Cross Ise Hospital, Mie (A.K.).7 Department of Cardiology, Kyorin University Hospital (T.S.), Tokyo, Japan.6 Department of Cardiology, National Hospital Organization Osaka National Hospital (K.H.), Tokyo, Japan.5 Department of Cardiology, Handa City Hospital (T.4 Department of Cardiology, Ichinomiya Municipal Hospital (T.3 Department of Cardiology, Nagoya City University Hospital (T.G.), Aichi, Japan.2 Department of Cardiovascular Surgery, Shizuoka City Shizuoka Hospital (F.Y.).1 Department of Cardiology, Fujita Health University School of Medicine, Aichi (E.W.).
0 kommentar(er)
